Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Desirudin
Latest prescription information about Desirudin. Learn how to pronounce the drug’s name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, its storage instructions and warnings if any when taken during pregnancy. Also listed are the International and Indian trade name(s) of the drug and its price list.
|
Generic Name : Desirudin
Pronunciation : deh-SIHR-uh-din
Therapeutic Classification : Anticoagulants / Antithrombotics
ICD Code : Y44.2
Trade Name(s): International- Revase, Iprivask. Why it is prescribed (Indications) : This medication is a parenteral anticoagulant, prescribed for prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism. It blocks the activity of thrombin, which helps in blood clot formation. When it is not to be taken (Contraindications): Contraindicated in patients with active bleeding and hypersensitivity.
Dosage & When it is to be taken : Adults - SC- 15 mg every 12 hour with the initial dose given up to 5 to 15 min before surgery, but after induction of regional block anesthesia if used. How it should be taken : It comes as a solution for injection to be administered by a healthcare provider into subcutaneous layer of the skin. Warnings and Precautions : *Caution should be exercised in patients with stomach ulcer, sugar, liver or kidney disease, stroke, bleeding in the eyes, bacterial endocarditis, during pregnancy and breastfeeding. * Administer only through subcutaneous method. * Activated partial thromboplastin time should be monitored in patients with increased risk of bleeding. * Monitor patient for signs of bleeding throughout therapy. Side Effects : Blood- Bleeding and blood clots. Heart- Obstruction in blood circulation, low blood pressure and stroke. Gastrointestinal- Nausea, vomiting and blood vomiting. Miscellaneous- Injection site mass, pus, anemia, inflammation of veins, severe allergic reactions, swelling in the leg, fever, blood in urine, dizziness and nose bleed. * Patient may develop with increased risk of developing an epidural or spinal blood clot, which can result in stroke. Storage Conditions : Store it at controlled room temperature (25o to 30oC), and in an airtight container. |
 Comment & Contribute
| ||
Browse the Drugs alphabetically
Reference
- Food and Drug Administration (FDA)
- National Institutes of Health (NIH)
- PubMed
- CIMS
- Indian Pharma Reference Guide 2012
Drugs Index
Pharma Links 
Recently added Drugs
Quick Links
Ask an Expert
